Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose esomeprazole + amoxicillin + metronidazole for pediatric double-resistant Helicobacter pylori infection
2006-002639-26Phase 3Completed
- Sponsor
- Dr. von Haunersches Kinderspital
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of esomeprazole, amoxicillin and metronidazole in Helicobacter pylori infection, sponsored by Dr. von Haunersches Kinderspital. Primary endpoint: Successful eradication of Helicobacter pylori after 14 days of therapy. Started Jan 2007; status: completed.
02
Drugs
esomeprazoleamoxicillinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on 2006-002639-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002639-26.